Pharmacologie cardiovasculaire
Tuesday, June 14, 2022
Sessions parallèles
Sessions parallèles
•
S15
•
4:30 PM
>
6:00 PM
•
Pharmacologie cardiovasculaire
•
Amphi Congrès
Sessions parallèles
Modérateurs : Jérémie BELLIEN (Rouen), Laurent BERTOLETTI (Saint-Etienne)
Conférence invitée
16h30 Pharmacology of the clot: towards improved thrombolysis in ischemic stroke - Simon DE MEYER (Louvain, Belgique)
Communications libres
•
CO-025
•
CO-025 - Risk of first ischemic stroke and use of antidopaminergic antiemetics: a nationwide case-time-control study
>
A.
Antoine
PARIENTE
•
CO-026
•
CO-026 - Gabapentinoid-induced peripheral edema and acute heart failure: a translational approach combining a nationwide pharmacovigilance study with preclinical experimental data
>
B.
Bérenger
Largeau
•
CO-027
•
CO-027 - Prevalence and bleeding risk associated with the concomitant use of direct oral anticoagulants and antiarrhythmic drugs in patients with atrial fibrillation, based on the french healthcare insurance database
>
L.
Laëtitia
Gosselin
•
CO-028
•
CO-028 - Inhibiting the phosphatase activity of soluble epoxide hydrolase reduces arterial calcification and prevents the cardiovascular complications of chronic kidney disease
>
H.
Hind
Messaoudi
•
CO-029
•
CO-029 - Heart valves penetration of amoxicillin in infective endocarditis patients: first results from the BELADIFF study.
>
S.
Sébastien
LALANNE
•
CO-030
•
CO-030 - Do 5-HT2B receptor agonists that recruit beta-arrestin 2 induce valvulopathy ?
>
E.
Estelle
AYME-DIETRICH
|